OTC Markets OTCPK - Delayed Quote USD
Grifols, S.A. (GIFOF)
8.25
0.00
(0.00%)
At close: May 13 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in EUR | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 8 | 11 |
| Avg. Estimate | 1.92B | 1.91B | 7.6B | 8.22B |
| Low Estimate | 1.92B | 1.91B | 7.54B | 7.99B |
| High Estimate | 1.92B | 1.91B | 7.68B | 8.61B |
| Year Ago Sales | 1.82B | 1.79B | 7.21B | 7.6B |
| Sales Growth (year/est) | 5.82% | 6.34% | 5.32% | 8.23% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GIFOF | -- | -- | -- | -- |
| S&P 500 | 13.20% | 2.98% | 8.01% | 13.77% |
Related Tickers
NOVA.SG Novo Nordisk A/S
59.50
+1.54%
VIRP.PA Virbac SA
304.75
-1.02%
REC.MI Recordati Industria Chimica e Farmaceutica S.p.A.
50.35
-2.71%
SAN.PA Sanofi
88.84
-0.97%
NONOF Novo Nordisk A/S
64.50
-0.86%
AZN.L AstraZeneca PLC
10,022.00
-1.55%
NOV.DE Novo Nordisk A/S
57.91
-1.09%
GSK.L GSK plc
1,360.00
+0.15%
NOVO-B.CO Novo Nordisk A/S
432.85
-1.31%
LLY Eli Lilly and Company
715.56
-4.09%